ArticleMedical oncology (Northwood, London, England)2019

Metronomic chemotherapy with cyclophosphamide plus low dose of corticosteroids in advanced castration-resistant prostate cancer across the era of taxanes and new hormonal drugs.

Nicola Calvani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.